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Preservation of human artery function following
prolonged cold storage with a new solution
Stephanie Garbe,a Birgit Zatschler,a Bianca Müller,a Peter Dieterich, PhD,a
Annette Ebner, PhD,a Ursula Rauen, MD, PhD,b Klaus Matschke, MD, PhD,c and
Andreas Deussen, MD, PhD,a Dresden and Essen, Germany
Objective:Blood vessels are an important tissue for allogenic vessel replacement surgery, which is needed for example following
infection of artificial grafts. For tissue banking, European legislation requires evidence of tissue sterility with assays performed
over 1 week. Currently, used cold storage solutions do not protect vascular function longer than 2 days. This does not allow
completion of microbiological testing. This discrepancy has almost completely stopped vessel banking in Europe.
Methods: We compared the recently developed storage solution TiProtec (Dr F Köhler Chemie, Bensheim, Germany) with
traditionally used histidine-tryptophan-ketoglutarate (HTK) solution, 0.9% NaCl, and phosphate-buffered saline
(physiological saline solution [PSS]) solution for extended cold (4°C) storage up to 25 days. Isolated rings of human
internal mammary artery were studied with respect to several parameters of vessel function, including vessel tone
development, endothelium-dependent and endothelium-independent relaxation, and tissue reductive capacity.
Results: Vessels stored in NaCl or PSS for>10 hours failed to develop tone after rewarming. Mammary arteries stored in
HTK for 4 hours at 4°C initially showed a well-preserved vessel function with respect to vessel tone development, as well
as endothelial and smooth muscle dilatative function. However, following 4 days of cold storage, vessel tone development
and dilatative responses were significantly impaired. In contrast, arteries stored in TiProtec showed full preservation of
vessel tone as well as endothelial and smooth muscle function after 4 days of cold storage. Even after 10 days of cold
storage, endothelium-dependent relaxation was approximately 50% of control, and smooth muscle function was fully
preserved. Over 2 weeks, tissue reductive capacity was significantly better maintained after cold storage in TiProtec
compared with vessels stored in NaCl.
Conclusions: In contrast to traditional HTK, NaCl, or PSS storage, TiProtec solution offers an excellent potential for
prolonged cold storage of human arteries, which may close the existing gap between legal requirements for tissue banking
and current cold preservation methods. (J Vasc Surg 2011;53:1063-70.)
Clinical Relevance: Currently used cold storage solutions do not protect vascular function for longer than 2 days. However,
current European legislation for tissue banking requires evidence of tissue sterility with assays performed over 1 week. This
discrepancy has almost completely stopped vessel banking in Europe. The present study convincingly shows that human vessel
function including endothelial protection can be well preserved for more than 10 days using the new potassium-rich, amino
acid-fortified storage solution TiProtec (Dr F Köhler Chemie, Bensheim, Germany). This solution offers an excellent potential
for prolonged cold storage which may close the existing gap between legal requirements for tissue banking and current cold
preservation methods. In addition, the results show that an optimized vessel protection during cold storage should use specific
storage solutions rather than common organ protection solutions.
e
p
a
g
f
i
1
r
b
a
c
i
w
p
e
t
fl
s
o
s
rBlood vessels are an important tissue to be preserved
and distributed by established tissue banks for allogenic
vessel replacement surgery. These include replacement of
vessels by allogenic veins and arterial vessels1 and may
include allogenic replacement due to vessel injury or steno-
sis in association with solid organ transplantations. How-
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doi:10.1016/j.jvs.2010.10.093ver, the availability of vascular tissues for transplantation
urposes is scarce.2 Beside difficulties in tissue donation
nd procurement, a major obstacle of vessel banking and
raft distribution is the maintenance of vessel physiological
unction and the documentation of tissue sterility. Follow-
ng European guidelines (guidelines 2004/23/EG; 2006/
7/EG), testing of tissue for microbial contamination is
equired by the German tissue law (issued July 20, 2007)
efore a tissue may be considered for distribution. While
ssays required for this testing run over a 1-week period,
urrently used solutions permit the cold storage of freshly
solated vessels for only much shorter periods (up to 2 days)
ithout loss of vessel function.3Maintenance of vessel, and in
articular endothelial cell function, seems important because
ndothelial injury during storage may promote postoperative
hrombosis and graft vasculopathy, causing low reperfusion
ow.4 Thus, legal requirements and currently used storage
olutions are discordant, impeding banking and distribution
f vessel grafts. Cryopreservation as an alternative to cold
torage of vessels also largely destroys endothelial integ-
ity and, therefore, does not represent an option to
aintain vascular function during storage.5
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April 20111064 Garbe et alWe have previously shown that a new preserva-
tion solution (TiProtec [Dr F Köhler Chemie, Bensheim,
Germany], which is a potassium-enriched, N-acetyl-
histidine buffered and amino acid-fortified solution
augmented with the iron chelators deferoxamine and 3,4-
dimethoxy-N-methyl-benzohydroxamic acid [LK 614]) per-
mits superior preservation of pig and rat aorta3,6 and rat
mesenteric artery.3 Vessel relaxation following endothelium-
dependent and endothelium-independent stimuli was pre-
served over at least 4 days of cold storage. In pig aorta,
well-preserved mitochondrial membrane potential and re-
duced platelet adherence to the endothelium could be dem-
onstrated even after 2 weeks of cold storage in TiProtec.
Furthermore, this new solution proved to be superior to the
widely used histidine-tryptophan-ketoglutarate (HTK) and
University of Wisconsin solutions.3,6 It is currently unknown
whether these very promising results obtained in animal ves-
sels are shared by human vessels. The use of human internal
mammary artery additionally permits proving the superiority
of the new solution on vessels affected by certain comorbidi-
ties such as diabetes mellitus or nicotine abuse. Also, it is
unknownwhether this new solution permits the propermain-
tenance of endothelial function of human vessels during a
prolonged cold storage of 7 days, as required by international
guidelines and the German tissue law.
Thus, the present study was designed to test the poten-
tial of the newly developed TiProtec solution for cold
storage of human arterial vessels over a period of up to 2
weeks. As an experimental model, we chose the human
internal mammary artery, which was available to us in the
course of regular coronary bypass surgery. As readouts for
vessel function, we tested endothelium-dependent and
endothelium-independent vessel relaxation. In addition, we
assessed poly (ADP-ribose) polymerase (PARP)-cleavage
fragment as a marker of apoptosis and mitochondrial reduc-
tive capacity in the vessel specimen with the resazurin reduc-
tion assay.
METHODS
The experimental project, conforming to National Insti-
tutes ofHealthGuidelines, was approved by the Ethical Com-
mittee of the TU Dresden (EK 307-12-2007). All clinical
investigations were conducted according to Declaration of
Helsinki principles. Patients provided written consent for the
use of the discarded tissues for research. Vessel segments were
randomly assigned for storage in either sodium chloride solu-
tion, physiological saline solution (PSS), HTK, or TiProtec
solution (both fromDrF.KöhlerChemie). The compositions
of the solutions are given in Table I. After transfer of vessels
from the surgical room to the laboratory in the respective
precooled solution, vessel segments (1-2 cm length) were
cleared from surrounding adipose and connective tissue and
stored (continuously at 4°C) for various periods of time (from
2hours up to25days). Then, vessel segmentswere transferred
to PSS solution, gently warmed to 37°C over 1.5 hours, and
subjected to function testing. tChemicals used in this study were obtained from Sigma
Munich, Germany), Merck (Darmstadt, Germany), or
arl Roth (Karlsruhe, Germany) unless stated otherwise.
Vessel function analysis. Vessel function was mea-
ured on segments as previously described in detail.3,7 In
rief, vessel rings (2 mm width) were studied in a Mulvany
yograph (DMT-610M; Power Laboratory/400, AD-
nstruments, Spechbach, Germany), stretched with a rest-
ng tension equivalent to an intraluminal pressure of 100
m Hg. At the end of cold storage, all segments were
ransferred to PSS solution and gently rewarmed to 37°C.
aximum contraction was induced by a high potassium
aline solution (KPSS with 123.7 mmol/L KCl).3 Vessel
elaxation toward acetylcholine and sodium-nitroprusside
as tested after constriction with 10 mol/L norepineph-
ine to assess endothelium-dependent and endothelium-
ndependent relaxations, respectively. To identify potential
echanisms of impairment, key enzymes were blocked
rior to subsequent testing for the acetylcholine response.
ndothelial production of nitric oxide was inhibited using
-N-monomethyl-arginine (L-NMMA, 100 mol/L). Cy-
looxygenase was blocked with indomethacin (3 mol/L).
Measurement of caspase-cleaved fragment p85 of
uman PARP. Tissues from vessels stored for 4 hours in
aCl or TiProtec solution were studied with and without
ewarming. Vessels were manually homogenized on ice in
.1 mol/L HEPES buffer (pH  7.4) as published.8
rotein content was determined by the amidoblack-
ethod.9 Proteins were separated by 12% sodium dodecyl
ulfate polyacrylamide gel electrophoresis and transferred
able I. Composition of the cold storage solutions used
ubstance (Mmol/L) TiProtec HTK PSS NaCl
-ketoglutarate 2 1 — —
spartate 5 — — —
istidine — 198 — —
-acetylhistidine 30 — — —
lycine 10 — — —
lanine 5 — — —
ryptophan 2 2 — —
ucrose 20 — — —
lucose 10 — 5.5 —
annitol — 30 — —
l 103.1 50 128.7 154
2PO4
 1 — 1.18 —
O4
2 — — 1.17 —
CO3
 — — 25 —
a 16 15 144 154
 93 10 5.9 —
g2 8 4 1.17 —
a2 0.05 0.015 2.5 —
DTA — — 0.027 —
eferoxamine 0.082 — — —
K 614 0.017 — — —
Ha 7.0 7.2 n.d. n.d.
smolarityb [mosmol/L] 305 310 320 308
.d., Not determined.
Measured at 20°C.
Calculated osmolarity.o a nitrocellulose membrane (Amersham, Freiburg, Ger-
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Volume 53, Number 4 Garbe et al 1065many) by electroblotting at 20 mA for 55 min. Relative
concentration of the caspase-cleaved fragment (p85) of
human PARP as an immunohistochemical index of apopto-
sis10 was assessed using rabbit antiPARP p85 fragment pAb
(1:200; Promega, Mannheim, Germany) as primary anti-
body and goat anti-rabbit IgG (1:1000; Dianova, Ham-
burg, Germany) as secondary antibody. Densitometric
semiquantitative analyses were performed with Image
Gauche software.
Reductive capacity. Vessels segments (5-10mm length)
stored either for 4 hours, or 4, 7, and 14 days in TiProtec or
NaCl were studied. To assess mitochondrial reductive capac-
ity, we used the resazurin reduction assay modified from
Zatschler et al.3 Usually, reductive capacity is determined as
percent of fluorescent product formed from resazurin under
“healthy” control conditions. Due to the transportation from
the department of cardiac surgery to the laboratory, no zero-
hour stored material was available to us. Therefore, we per-
formed external calibration with resorufin, the fluorescent
product of resazurin reduction. The coefficient of variation
was 0.23. Limit of detection was 50 nmol/L, which is the
concentrationwhen resorufin fluorescence is equivalent to the
background-fluorescence of the added substrate resazurin (1
mol/L).Vesselswere incubatedwith the substrate diluted in
200 L PSS solution for 60 minutes. Fluorescence measure-
ments were performed at ex  530-nm excitation wave-
length and em 590-nm emission wavelength.
Patient data. The patient data were collected from the
clinical records in a single blinded manner including pres-
ence of hypertension, hypercholesterolemia, diabetes mel-
litus, obesity (body mass index 30 kg/m2), and current
Table II. Patient data of vessels used in the study of vesse
Parameters TiPr
Number of patients 4
Males 3
Females
Age (mean  SEM) 69.1 
Risk factors (% of all patients of respective group)
Arterial hypertension 10
Hypercholesterolemia 7
Diabetes mellitus 5
Obesity – body mass index 30 kg/m2 2
Current smokers 2
Past smokers 1
Medication (% of all patients of respective group)
Angiotensin-converting enzyme-inhibitors 6
Angiotensin-2 receptor blockers 2

-blockers 8
Statins 7
Acetylsalicylic acid 8
Clopidogrel 4
Calcium channel blockers 2
Nitrates 4
HTK, Histidine-tryptophan-ketoglutarate; PSS, physiological saline solution
aP  .05 vs PSS.
bP  .05 vs HTK, NaCl.
cP  .05 vs TiProtec.
dP  .05 vs TiProtec.and previous smoking status. Also, the actual medication, ancluding angiotensin-converting enzyme inhibitors,
ngiotensin-2 receptor blockers, beta-blockers, calcium
hannel blockers, statins, nitrates, acetylsalicylic acid, and
lopidogrel, was recorded.
Data analysis and statistics. Dose-response curves
ere evaluated as described before.3 The time-dependent
oss of relaxation capacity was assessed using sigmoidal
urve fitting. Data are presented as mean values  their
tandard errors (SEM). Data were analyzed for normal
istribution (Kolmogorov-Smirnov test with modifica-
ion after Lilliefors) and homogeneity of variances (Lev-
ne). Differences of responding vessels (responders/
on-responders) per group were assessed using 	2
tatistics. Intergroup differences to stimuli were tested us-
ng one-way analysis of variance (ANOVA) with post-hoc
ultiple comparisons or Student t test. A P value of 0.05 or
ess (two-sided) was taken to indicate a significant differ-
nce. Data analysis was performed using SPSS-program
ersion 15.0 (SPSS Inc, Chicago, Ill).
ESULTS
Vessel segments for functional testing were obtained
rom 133 patients undergoing bypass grafting because of
evere coronary heart disease. The clinical data are summa-
ized in Table II. There were differences between PSS and
aCl groups with respect to the age and the status of
urrent smokers despite random grouping. However, the
otal incidence of smoking (current smokers plus past
mokers) was similar in the various study groups. Medica-
ion before admission to heart surgery was similar for the
ifferent groups. The vessel segments (1-2 cm long) were
ction
HTK PSS NaCl
34 16 23
24 14 18
10 2 5
68.6  1.6 64.4  2.0 70.4  1.8a
97 94 96
65 63 74
41 44 61
32 31 26
9 38b 0c
24 19 30
68 81 70
24 19 26
85 69 70
74 94 91
85 94 83
21d 13d 26
12 31 26
35 25 52l fun
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April 20111066 Garbe et alof the patient identity and the patient history. If possible, a
segment was split and used for different analyses/time points.
Vessel tension development. Following 4 hours cold
storage in TiProtec, HTK, or PSS, vessel rings generally
responded to stimulation by norepinephrine (Table III).
However, the magnitude of tension development clearly
differed between the various storage conditions (Fig 1).
Tension development after exposure to norepinephrine (10
mol/L) was significantly higher when tissues had been
stored in TiProtec versus storage in HTK. The tension
development was significantly lower after NaCl storage as
compared with TiProtec and HTK storage (P  .05).
Pronounced differences existed between the groups after
Table III. Failure rate of vessel tone development in KPSS
Storage solution TiProtec HTK PSS NaCl
Short-term storage (4 hours)
N 33 52 13 24
Failure 0 0 0 6a
Medium-term storage (24 hours)
N — — 8 5
Failure — — 8 5
Long-term storage (96 hours)
N 27 32 — —
Failure 0 7b — —
N, Total number of vessel segments analyzed including failing vessels.
aP  .05 vs TiProtec, HTK, PSS.
bP  .05 vs TiProtec.
Fig 1. Vessel tension development measured at 37°C after stimula-
tionwith norepinephrine (10mol/L).Data include nonresponding
vessels as listed inTable III. Vessel segments cold-stored in 0.9%NaCl
showed a significantly depressed vessel tension compared with TiPro-
tec andHTK-stored vessels. Vessel segments stored inHTK for 4days
developed a significantly lower vessel tension compared with those
stored only 4 hours in HTK and compared with segments stored for
4 days in TiProtec. n.d., Not determined.96 hours’ (4 days) cold storage. At this time, only vessels atored in TiProtec exhibited a tension development that
as similar to that after 4 hours of storage. Tension devel-
pment was severely decreased after 4 days’ cold storage in
TK (P  .05). Vessels stored in PSS and NaCl for more
han 10 hours generally failed to develop tone in response to
orepinephrine. Therefore, no relaxation experiments could be
arried out after 4 days’ cold storage in PSS or NaCl solutions.
essels stored in HTK for 4 days showed a significantly in-
reased failure rate as compared with tissues stored in
iProtec (Table III). Storage in NaCl or PSS, solutions
requently used in bypass surgery, resulted in a total loss
f vessel function within 24 hours after isolation.
Smooth muscle dilative function. To assess relax-
tion property of smooth muscle cells, vessels stored 4
ours and 4 days in respective solutions were, after rewarm-
ng in PSS solution, preconstricted with 10 mol/L nor-
pinephrine and subsequently exposed to stepwise in-
reases of the sodium-nitroprusside concentration (Fig 2).
ollowing cold storage for 4 hours, all storage groups
howed similar results: Maximal relaxation was 80% to 90%,
nd concentration for half-maximal relaxation ranged from
06.1 mol/L (NaCl, TiProtec) to 106.9 mol/L (PSS
nd HTK). After 4 days’ cold storage, neither concentration
esponse curves nor maximal relaxation differed when the
pecimen had been exposed to TiProtec or HTK and if only
essel segments responding to norepinephrine were included.
owever, as shown in Table III, the failure rate (no response
o high potassium solution) of vessels stored in HTK for 4
ays was 22% (7/32) versus zero failure after TiProtec storage
P  .05). Smooth muscle relaxation after 4 days of PSS or
aCl storage could not be assessed due to complete lack of
essel tone.
Endothelium-dependent relaxation. The acetylcholine-
nduced response of vessels stored 4 hours and 4 days in
he different solutions is shown in Fig 3. After 4 hours’ cold
torage in TiProtec or HTK, the concentration response
urves did not differ, and maximal relaxations were 77% 
2% and 70%  10%, respectively. The negative decadic
ogarithm of half-maximal effective concentration (pEC50)
as calculated to be 6.7  0.3 for TiProtec and 7.2  0.2
or HTK solution (n.s.). Concentration response curves for
cetylcholine were shifted to the right after cold storage in
SS (pEC50 6.0 0.3 for PSS vs pEC50 6.7 0.3 for
iProtec). Maximal relaxations were similar after storage in
SS (62%  12%) and NaCl (59%  19%).
After 4 days’ cold storage, an unchanged concentration
esponse curve was obtained only for TiProtec. A blunted
esponse was obtained after storage in HTK (maximum
elaxation 44%  12%, P  .05 vs TiProtec 96 hours).
essels stored in HTK generally maintained the relaxation
oward sodium-nitroprusside (SNP) after 4 days’ cold stor-
ge (if they responded toward high potassium solution).
hus, HTK vessel storage primarily resulted in an injury
f the endothelium-dependent relaxation. Please note
gain, Fig 3 only contains vessels that responded to KPSS
Table III). Because there were no failures (and thus no
ata exclusion) in the TiProtec group, but a failure rate of
pproximately 22% in the HTK group (Table III), the differ-
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Volume 53, Number 4 Garbe et al 1067ence between both groups would even be larger if all data
including non-responders would have been used to construct
the concentration-response curves. Vessel relaxation in re-
sponse to acetylcholine could not be studied after 4 days of
storage in PSS or NaCl because these vessels failed to contract
Fig 2. Vessel relaxation responses to stimulation with sodi
(right panel) cold storage measured at 37°C. Symbols denote
Cold storage conditions were TiProtec (4 hours, n 20; 96
(4 hours, n  9; 96 hours, n  0), or NaCl (4 hours, n 
vessels which responded with tension development followin
Fig 3. Vessel relaxation responses to stimulation with a
(right panel) cold storage as a measure of endothelium-
measured relaxation; lines represent the calculated sigmo
96 hours, n 17), HTK (4 hours, n 25; 96 hours, n
n 10; 96 hours, n 0), all at 4°C.Curveswere calculate
following exposure to 123 mmol/L KCl (KPSS) and no
ACH-evoked dilatation was better preserved compared wtoward high potassium and norepinephrine. aPotassium-enriched cold storage solution and en-
othelium-derived hyperpolarizing factor (EDHF).
t has been postulated11,12 that long-term storage in K-
nriched solutions impairs EDHF-mediated relaxation. As
iProtec is a potassium-enriched solution, we assessed the
troprusside (SNP) after 4 hours (left panel) and 96 hours
sured relaxation, lines represent the calculated sigmoidal fits.
, n 18), HTK (4 hours, n 23; 96 hours, n 12), PSS
hours, n  0), all at 4°C. Curves were calculated only for
osure to potassium enriched solution and norepinephrine.
holine (ACH) after 4 hours’ (left panel) and 96 hours’
dent vessel function measured at 37°C. Symbols denote
ts. Storage conditions were TiProtec (4 hours, n  21;
SS (4 hours, n 9; 96 hours, n 0), or NaCl (4 hours,
ly for vessels which responded with tension development
ephrine. Following 4 days of cold storage in TiProtec,
essel segments stored in HTK for 4 days.um-ni
mea
hours
10; 96cetylc
depen
idal fi
14), P
d on
repinction of inhibitory agents on the presumed EDHF-dependent
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April 20111068 Garbe et alvessel relaxation after 4 hours and 4 days of cold storage
in TiProtec, respectively (Fig 4). EDHF-mediated relax-
ation of human internal mammary arteries was assessed as
the relaxation response toward acetylcholine under inhibi-
tion of nitric oxide (NO) synthase and cyclooxygenase.13
For both storage periods, inhibition of NO synthase by
L-NMMA, as well as inhibition of cyclooxygenase by indo-
methacin, reduced the acetylcholine-induced relaxation by
approximately 50%. Combination of both blockers did not
enhance the inhibition, suggesting that both signaling
pathways are redundant. Results did not differ after 4 hours
and 4 days of cold storage, respectively.
Long-term storage (2 weeks). The results on pro-
longed vessel cold storage in NaCl, PSS, and TiProtec are
depicted in Fig 5. Regression fits revealed highly significant
differences between the groups when comparing the time at
which relaxation capacity had decreased by 50% (RC50%).
RC50% was 10 days for acetylcholine-induced relaxation and
longer than 2weeks for SNP relaxation after TiProtec storage.
Fig 5 also shows the early relaxation failure of vessels stored in
NaCl (RC50%: ACH: 9 1 h; SNP: 10 1 h) or PSS (RC50%:
ACH: 11 1 h; SNP: 16 1 h) for comparison.
Reductive capacity. Reductive capacity (vessels of 46
patients) did not decrease until 2 weeks of cold storage in
TiProtec, although there was a nonsignificant trend (.05
P  .20) for a decrease after 4 and 14 days (Fig 6). In
contrast, a significant time-dependent decrease of the re-
ductive capacity was observed during cold storage in NaCl.
sP85 fragment measurement. The functional data
convincingly show that vessel function was well preserved
Fig 4. Maximum relaxation in response to acetylcholine (ACH) of
vessels cold-stored in TiProtec for 4 hours (n 21 each) or 96 hours
(n 18 each) with andwithout preincubation with various inhibitors
of relaxation pathways measured at 37°C. There was no significant
difference between the responses seen after 4 and 96 hours of cold
storage independent of the respective inhibitor protocol. control,
ACH relaxation prior to inhibitor treatment; L-NMMA, block of
eNOS; indo-, block of cyclooxygenase; L-NMMA/indo-, block of
eNOS and cyclooxygenase equivalent to EDHF-mediated relaxation.following prolonged cold storage and rewarming. To fur- rher elucidate the protection against cold injury versus
ewarming, we measured sP85 fragment formation from
ARP as an indicator of apoptotic processes.10 Measure-
ent of caspase-cleaved fragment p85 of PARP on vessels
as performed on an additional group of 29 vessels (Fig 7).
ewarmed and nonrewarmed segments stored for 4 hours
n TiProtec or 0.9% NaCl-solution were compared. West-
rn blot analysis indicated approximately 100-fold higher
85 levels as compared to nonrewarmed segments in both
iProtec and NaCl-stored vessels. Relative protein amounts
ere similar in both groups.
ISCUSSION
The findings of the present study extend those of two
ecent studies performed on rat superior mesenteric artery3
ndonpig aorta.6 Both studies showed excellent protectionof
issues with TiProtec solution in these models of animal ves-
els. The current study extends the assessment to human
nternal mammary artery, a vessel routinely used for arterial
ypass grafting. The current results exceed those of the previ-
us studies in several aspects: 1) optimized protection with
iProtec is relevant for vessels obtained from patients with
ig 5. Vessel relaxation responses to stimulation with acetylcho-
ine (ACH) (upper panel) and sodium-nitroprusside (SNP, lower
anel) measured at 37°C. Symbols denote measured maximum
elaxation values; lines indicate the calculated fits. Cold storage
onditions were TiProtec (90 vessel segments), PSS (41 vessel
egments), or NaCl (68 vessel segments).elevant comorbidities; 2) the duration of cold storagemay be
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Volume 53, Number 4 Garbe et al 1069extended to 7 to 14 days, which increases the clinical potential
of cold storage tremendously; 3) cold storage in TiProtec
preserves the cyclooxygenase pathway, which had not been
Fig 6. Reductive capacity following cold storage in TiProtec (2
hours, n  12; 96 hours, n  8; 168 hours, n  16; 336 hours,
n 12) or NaCl (2 hours, n 5; 96 hours, n 12; 168 hours, n
10; 336 hours, n 9) measured at 37°C. Reduction of resazurin to
resorufin is significantly decreased in vessels stored in NaCl for 7
days compared with 7 days storage in TiProtec. The variation in
reductive capacity in vessels stored in TiProtec did not reach the
level of significance (P  .2).
Fig 7. Relative protein amount of the caspase-cleaved fragment
(p85) of human PARP as an immunohistochemical marker of
apoptosis. After 4 hours’ cold storage in NaCl (n  9), sP85 level
is nonsignificantly (P  .2) elevated compared with TiProtec
storage (n  14). After 4 hours of cold storage and 2 hours
rewarming in PSS, a hundred-fold increase in PARP-sP85 level was
detected independent of the preservation solution used (P  .004
in TiProtec [n  7], P  .099 in NaCl [n  6]).tested before. pEndothelial function is especially important for preven-
ion of postoperative graft thrombosis and stenosis.4 The
resent study objectified improved preservation by measure-
ent of vessel tone development following stimulation with
orepinephrine, endothelium-dependent vessel relaxation,
ndothelium-independent vessel relaxation, and tissue reduc-
ive capacity. In long-term storage (4 days), the established
ardioplegic solution, HTK, and the frequently used bypass
raft storage solutions,NaCl, andPSSwere unable to preserve
ndothelial and smoothmuscle function to a similar extent. In
ddition to a more pronounced loss of endothelium-depen-
ent relaxation after cold storage in these solutions, also, the
ailure rate to develop smoothmuscle tone when exposed to a
igh potassium concentration was significantly increased after
nly 4 hours in NaCl, 24 hours in PSS, and 96 hours in HTK
Table III). The poor protection provided by HTK is well
ompatible with that observed in a previous study,14 in which
reduced dilator capacity of coronary resistance vessels had
een evidenced after 8 hours’ cold storage of rat heart in
TK. In summary, based on the results of the current study
nd three previously published data sets from our laborato-
ies,3,6,14 the use of HTK and even less that of PSS cannot be
ecommended for prolonged cold storage of vessel segments.
niversity of Wisconsin solution, the solution used most
requently for cold storage inNorthAmerica,was not tested in
he present study. The reasons are several-fold. University of
isconsin solutionhas been tested in detail in a previous study
n comparison with the new TiProtec solution by Wille et al6.
here, endothelial cell damage, as measured by propidium
odide staining and a decreased mitochondrial potential, was
ignificantly more advanced in pig aortic endothelial cells
tored in University of Wisconsin solution than in TiProtec
olution. Because the availability of human vessels was limited,
e decided to test TiProtec against HTK solution, which is
lso more commonly used in Europe for cold preservation.
Previously, the role of a high potassium concentration
or the maintenance of endothelial function, and, in partic-
lar for EDHF-mediated vasorelaxation, has been dis-
ussed controversially in literature.11,12,15 Because species
ifferences may explain these controversies to some extent,
e have addressed this issue on the example of the human
nternal mammary artery. In this vessel, EDHF is most likely
dentical with 11,12-epoxy-eicosatrienoic acid (11,12-EET),
lipid produced by cytochrome p450 in response to acetyl-
holine and bradykinin.13 Under block of eNOS and cyclo-
xygenase, approximately 50% of the original acetylcholine-
nduced mammary artery relaxation remained (Fig 4). This
emaining relaxation could be blunted completely by addi-
ional administration of charybdotoxin plus apamine, inhibi-
ors of KCa-dependent relaxation (data not shown). Because
he effects of these blockers were not significantly different
fter 4 hours’ and 4 days’ cold storage, this strongly suggests
hat EDHF-mediated relaxation was well preserved during
torage in TiProtec. Additionally, our experiments provide
vidence that not only the contributions of nitric oxide but
lso those of cyclooxygenase products were quantitatively
reserved over at least 4 days of cold storage.
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April 20111070 Garbe et alAlthough storage in TiProtec was drastically superior
over NaCl with respect to functional measurements, no
differences in P85 fragment (ourmeasure of caspase activity
as indicator for apoptotic processes) were observed after
rewarming. This points to a process related to the rewarming
procedure rather than the cold storage, because cold storage
for 14 days in TiProtec did not elevate P85 fragment concen-
tration (data not shown). It is emphasized, however, that
vessel tone development and relaxation parameters were ana-
lyzed also after rewarming. We therefore conclude that cleav-
age of PARP fragment P85 does not immediately influence
vessel function. Nonetheless, future studies should target on
improving protection during the rewarming period.
The composition of TiProtec differs largely from organ
preservation solutions in current clinical use (eg, HTK,
University ofWisconsin solution), especially with respect to
the physiological extracellular chloride concentration, the
slightly acidic pH, and the iron chelators.3,6 Because vessel
protection during storage in TiProtec is superior to that in
HTK (3,6 and this study) and University of Wisconsin
solutions,6 it should be considered for future storage of
vessel specimen in vascular and transplantation surgery. In
transplantation surgery, the additional vessels harvested for
(potential) vascular reconstruction should then be kept
separate from the solid organ and stored in TiProtec.
Study limitation. We have used the human internal
mammary artery, a vessel frequently used for coronary bypass
grafting. Thus, the results obtained are immediately relevant
for this graft vessel. However, most coronary bypass grafts are
taken from saphenous vein, and vessel banking is most rele-
vant for infrarenal arterial and venous vessels. These vessels
were not available to us for the present study.
The currently used ex vivo assays assessed function of
small and medium-sized arteries, namely vasodilation and
vasoconstriction as a general measure of intact cell metabo-
lism. Furthermore, the experimental set-up included the re-
warming period. Thus, both periods of acute injury were
covered.16 The outcome of the present study warrants future
experimental vessel transplantation studies to test for optimized
preservation (eg, reduced post-transplant vessel inflammation).
CONCLUSIONS
The new solution will permit safe storage of human and
animal vessel grafts for extended periods of time (7-14 days).
This may offer the potential to extend the interval between
vessel explantation and vascular surgery, to store vessel seg-
ments for later revision surgery, and to develop innovative
storage protocols for banking of grafts with the perspective of
later heterologous transplantation.ThenewTiProtec solution
may also serve researchers to use vessels for experimental
purposes froma stock even after aweek of proper cold storage.
The authors thank Dr Martina Wendel for her help in
establishing the PARP cleavage assay.
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